Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
CRISPR Therapeutics AG (NASDAQ:CRSP) is trading higher Friday morning after the company announced second-quarter financial results that showed significant improvement year over year.
CRISPR Therapeutics reported quarterly earnings of $9.44 per share, which was up from a loss of $1.30 per share year over year. The company reported quarterly revenue of $900.2 million, which was up from revenue of less than $100,000 year over year.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
“We concluded an important quarter in which we reported notable data from our hemoglobinopathies program while rapidly advancing our entire clinical and pre-clinical portfolio and our capabilities,” said Samarth Kulkarni, CEO of CRISPR Therapeutics.
CRISPR Therapeutics is a biotechnology company focused on gene-editing.
Price Action: CRISPR Therapeutics has traded as high as $220.20 and as low as $76.71 over a 52-week period.
At last check Friday, the stock was up 4.20% at $124.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.